Literature DB >> 17223708

Thermodynamic characterization of the interaction between CAR-RXR and SRC-1 peptide by isothermal titration calorimetry.

Edward Wright1, Jeremy Vincent, Elias J Fernandez.   

Abstract

The constitutive androstane receptor (CAR) enhances transcription of specific target genes that regulate several metabolic pathways. CAR functions as an obligate heterodimer (CAR-RXR) with the retinoid X receptor (RXR). Also part of the active receptor complex is the steroid receptor coactivator-1 (SRC-1) which interacts with the receptor complex via specific receptor interaction domains (RIDs). A peptide derived from SRC-1 RID2 is used to study the thermodynamic properties of the interaction with the CAR-RXR ligand binding domain (LBD) complex. In the absence of ligands for both CAR and RXR, binding of coactivator peptide to the CAR-RXR heterodimer is characterized by a favorable enthalpy change and an unfavorable entropy change. The addition of the CAR agonist, TCPOBOP, increases the affinity for coactivator by decreasing the unfavorable entropy and increasing the favorable intrinsic enthalpy of the interaction. The RXR ligand, 9-cis-RA, generates a second SRC-1 site and increases the affinity by improving the entropic component of binding. There is an additional increase in affinity for one of the two sites in the presence of both ligands. The change in heat capacity (deltaCp) is also investigated. A 2-fold difference in deltaCp is observed between liganded and unliganded CAR-RXR. The observed thermodynamic parameters for binding of SRC-1 peptide to liganded and apo CAR-RXR as well as the difference in the deltaCp data provide evidence that the apo CAR-RXR heterodimer is conformationally mobile. The more favorable enthalpic contribution for TCPOBOP-bound CAR-RXR indicates that preformation of the binding site improves the complementarity of the coactivator-receptor interaction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17223708      PMCID: PMC2518310          DOI: 10.1021/bi061627i

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  47 in total

1.  The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism.

Authors:  P Wei; J Zhang; M Egan-Hafley; S Liang; D D Moore
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

2.  Structural determinants of allosteric ligand activation in RXR heterodimers.

Authors:  Andrew I Shulman; Christopher Larson; David J Mangelsdorf; Rama Ranganathan
Journal:  Cell       Date:  2004-02-06       Impact factor: 41.582

3.  The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization.

Authors:  Kelly Suino; Li Peng; Ross Reynolds; Yong Li; Ji-Young Cha; Joyce J Repa; Steven A Kliewer; H Eric Xu
Journal:  Mol Cell       Date:  2004-12-22       Impact factor: 17.970

4.  Configurational effects in antibody-antigen interactions studied by microcalorimetry.

Authors:  K P Murphy; E Freire; Y Paterson
Journal:  Proteins       Date:  1995-02

5.  Evaluation of linked protonation effects in protein binding reactions using isothermal titration calorimetry.

Authors:  B M Baker; K P Murphy
Journal:  Biophys J       Date:  1996-10       Impact factor: 4.033

6.  Rapid measurement of binding constants and heats of binding using a new titration calorimeter.

Authors:  T Wiseman; S Williston; J F Brandts; L N Lin
Journal:  Anal Biochem       Date:  1989-05-15       Impact factor: 3.365

7.  Estimation of changes in side chain configurational entropy in binding and folding: general methods and application to helix formation.

Authors:  K H Lee; D Xie; E Freire; L M Amzel
Journal:  Proteins       Date:  1994-09

8.  Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain.

Authors:  Natalie K Goto; Tsaffrir Zor; Maria Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  J Biol Chem       Date:  2002-08-29       Impact factor: 5.157

9.  A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity.

Authors:  Isabelle Dussault; Min Lin; Kevin Hollister; Ming Fan; John Termini; Mark A Sherman; Barry M Forman
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

10.  9-cis retinoic acid is a high affinity ligand for the retinoid X receptor.

Authors:  R A Heyman; D J Mangelsdorf; J A Dyck; R B Stein; G Eichele; R M Evans; C Thaller
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

View more
  16 in total

Review 1.  Allosteric pathways in nuclear receptors - Potential targets for drug design.

Authors:  Elias J Fernandez
Journal:  Pharmacol Ther       Date:  2017-10-31       Impact factor: 12.310

2.  Structure, energetics, and dynamics of binding coactivator peptide to the human retinoid X receptor α ligand binding domain complex with 9-cis-retinoic acid.

Authors:  Gang Xia; LeeAnn J Boerma; Bryan D Cox; Cheng Qiu; Sebyung Kang; Craig D Smith; Matthew B Renfrow; Donald D Muccio
Journal:  Biochemistry       Date:  2010-12-08       Impact factor: 3.162

3.  Direct interdomain interactions can mediate allosterism in the thyroid receptor.

Authors:  Balananda-Dhurjati K Putcha; Elias J Fernandez
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

4.  Common architecture of nuclear receptor heterodimers on DNA direct repeat elements with different spacings.

Authors:  Natacha Rochel; Fabrice Ciesielski; Julien Godet; Edelmiro Moman; Manfred Roessle; Carole Peluso-Iltis; Martine Moulin; Michael Haertlein; Phil Callow; Yves Mély; Dmitri I Svergun; Dino Moras
Journal:  Nat Struct Mol Biol       Date:  2011-04-10       Impact factor: 15.369

5.  SRC-3 is required for CAR-regulated hepatocyte proliferation and drug metabolism.

Authors:  Tenghui Chen; Qiang Chen; Yixiang Xu; Qiling Zhou; Jingwei Zhu; Hao Zhang; Qiao Wu; Jianming Xu; Chundong Yu
Journal:  J Hepatol       Date:  2011-08-07       Impact factor: 25.083

Review 6.  Drug discovery technologies to identify and characterize modulators of the pregnane X receptor and the constitutive androstane receptor.

Authors:  Sergio C Chai; Wenwei Lin; Yongtao Li; Taosheng Chen
Journal:  Drug Discov Today       Date:  2019-02-04       Impact factor: 7.851

7.  Ligand binding and heterodimerization with retinoid X receptor α (RXRα) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding.

Authors:  Na Wang; Qingan Zou; Jinxin Xu; Jiancun Zhang; Jinsong Liu
Journal:  J Biol Chem       Date:  2018-10-01       Impact factor: 5.157

8.  Agonist ligands mediate the transcriptional response of nuclear receptor heterodimers through distinct stoichiometric assemblies with coactivators.

Authors:  Mark Remec Pavlin; Joseph S Brunzelle; Elias J Fernandez
Journal:  J Biol Chem       Date:  2014-07-22       Impact factor: 5.157

9.  Structural and functional analysis of the human nuclear xenobiotic receptor PXR in complex with RXRα.

Authors:  Bret D Wallace; Laurie Betts; Garrick Talmage; Rebecca M Pollet; Natalie S Holman; Matthew R Redinbo
Journal:  J Mol Biol       Date:  2013-04-16       Impact factor: 5.469

10.  The Nrf2 activator oltipraz also activates the constitutive androstane receptor.

Authors:  Matthew D Merrell; Jonathan P Jackson; Lisa M Augustine; Craig D Fisher; Angela L Slitt; Jonathan M Maher; Wendong Huang; David D Moore; Youcai Zhang; Curtis D Klaassen; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2008-05-12       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.